Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Other Operating Expenses (2020 - 2025)

Pulse Biosciences (PLSE) has 4 years of Other Operating Expenses data on record, last reported at $260000.0 in Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $260000.0; the TTM value through Dec 2025 reached $539000.0, changed N/A, while the annual FY2025 figure was $539000.0, N/A changed from the prior year.
  • Other Operating Expenses reached $260000.0 in Q4 2025 per PLSE's latest filing, down from $279000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $12.9 million in Q1 2021 and bottomed at $260000.0 in Q4 2025.
  • Average Other Operating Expenses over 3 years is $5.0 million, with a median of $4.6 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 2388.55% in 2021, then tumbled 61.11% in 2022.
  • A 3-year view of Other Operating Expenses shows it stood at $5.3 million in 2021, then crashed by 61.11% to $2.1 million in 2022, then plummeted by 87.37% to $260000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $260000.0 in Q4 2025, $279000.0 in Q3 2025, and $2.1 million in Q4 2022.